Its a daily tablet that comes in a 7mg and 14mg dose and is indicated for type 2 diabetes
That could explain the lower dementia risk seen in humans
Direct-to-Consumer (DTC) Weight-Loss Medication Market Drivers Growing Approvals and Adoption of GLP-1-Based Therapies The adoption of GLP-1 receptor agonists is rapidly transforming the landscape of the direct-to-consumer (DTC) weight-loss medication market, emerging as a key growth driver
Research indicates that catechins possess numerous health-promoting properties, notably benefiting cardiovascular disease, metabolic syndrome, diabetes, cancer, stroke, and neurodegenerative diseases (Figure 1) (29)
The expression of the Tfr1 protein was elevated by HT treatment, which also decreased the levels of Nrf2, SLC7A11, GPX4, and NQO1 proteins in HCT116 cells (Fig